1. Home
  2. KALV vs SXC Comparison

KALV vs SXC Comparison

Compare KALV & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$16.12

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Logo SunCoke Energy Inc.

SXC

SunCoke Energy Inc.

HOLD

Current Price

$7.91

Market Cap

549.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
SXC
Founded
N/A
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
551.2M
549.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KALV
SXC
Price
$16.12
$7.91
Analyst Decision
Strong Buy
Hold
Analyst Count
5
1
Target Price
$30.00
$10.00
AVG Volume (30 Days)
1.3M
994.6K
Earning Date
03-11-2026
02-17-2026
Dividend Yield
N/A
6.08%
EPS Growth
N/A
N/A
EPS
N/A
0.75
Revenue
$1,426,000.00
$1,843,100,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$204.16
$4.94
P/E Ratio
N/A
$10.54
Revenue Growth
N/A
N/A
52 Week Low
$8.74
$6.24
52 Week High
$19.00
$10.08

Technical Indicators

Market Signals
Indicator
KALV
SXC
Relative Strength Index (RSI) 54.89 53.70
Support Level $15.22 $7.66
Resistance Level $16.16 $8.16
Average True Range (ATR) 0.88 0.26
MACD -0.01 -0.05
Stochastic Oscillator 76.95 34.33

Price Performance

Historical Comparison
KALV
SXC

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About SXC SunCoke Energy Inc.

SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is primarily used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.

Share on Social Networks: